Samarth Kulkarni sold $5.2M of CRISPR Therapeutics AG (CRSP)

Executed Jan 20, disclosed Jan 22, 2 days later.

Value, as filed

$5.2M

90,000 sh across 3 lots

Executed

Jan 20

the trade date, as filed

Disclosed

Jan 22

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Samarth Kulkarni Chief Executive Officer profile →

Samarth Kulkarni (Chief Executive Officer) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in CRISPR Therapeutics AG (CRSP). The largest single filing was $5.2M of CRSP (90,000 sh across 3 lots, as filed), executed Jan 20.

The name

CRSP

CRISPR Therapeutics AG CRSP · Healthcare · 34 filings in 24 months ticker →

Healthcare · CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered R…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Samarth Kulkarni in CRSP

CRSPSALE CRISPR Therapeutics AG $469K
10,020 sh × $46.78
Exec Mar 23
Filed Mar 24 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG $499K
10,349 sh × $48.26
Exec Mar 16
Filed Mar 17 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG $517K
9,798 sh × $52.80
Exec Mar 11
Filed Mar 12 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG $366K
6,967 sh × $52.58
Exec Feb 19
Filed Feb 20 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG $3.5M
50,895 sh × $67.91
Exec Oct 17 2025
Filed Oct 20 2025 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG $283K
4,242 sh × $66.60
Exec Oct 14 2025
Filed Oct 15 2025 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG $761K
13,081 sh × $58.15
Exec Aug 18 2025
Filed Aug 19 2025 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG $414K
10,031 sh × $41.23
Exec Mar 21 2025
Filed Mar 24 2025 · 5:30 PM ET